Radiotherapy Timing in 4,820 Patients With Breast Cancer: University of Florence Experience


      To analyze the relationship between a delay in radiotherapy (RT) after breast-conserving surgery and ipsilateral breast recurrence (BR).

      Methods and Materials

      We included in our analysis 4,820 breast cancer patients who had undergone postoperative RT at the University of Florence. The patients were categorized into four groups according to the interval between surgery and RT (T1, <60 days; T2, 61–120 days; T3, 121–180 days; and T4, >180 days).


      On multivariate analysis, the timing of RT did not reach statistical significance in patients who received only postoperative RT (n = 1,935) or RT and hormonal therapy (HT) (n = 1,684) or RT, chemotherapy (CHT), and HT (n = 529). In the postoperative RT-only group, age at presentation, surgical margin status, and a boost to the tumor bed were independent prognostic factors for BR. In the RT plus HT group, age at presentation and boost emerged as independent prognostic factors for BR (p = 0.006 and p = 0.049, respectively). Finally, in the RT, CHT, and HT group, only multifocality was an independent BR predictor (p = 0.01). Only in the group of patients treated with RT and CHT (n = 672) did multivariate analysis with stepwise selection show RT timing as an independent prognostic factor (hazard ratio, 1.59; 95% confidence interval, 1.01–2.52; p = 0.045). Analyzing this group of patients, we found that most patients included had worse prognostic factors and had received CHT consisting of cyclophosphamide, methotrexate, and 5-fluorouracil before undergoing RT.


      The results of our study have shown that the timing of RT itself does not affect local recurrence, which is mainly related to prognostic factors. Thus, the “waiting list” should be thought of as a “programming list,” with patients scheduled for RT according to their prognostic factors.
      To read this article in full you will need to make a payment
      ASTRO Member Login
      ASTRO Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features.

      Purchase one-time access:

      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Fletcher G.H.
        Implications of the density of clonogenic infestation in radiotherapy.
        Int J Radiat Oncol Biol Phys. 1986; 12: 1675-1680
        • Withers H.R.
        Biologic basic for altered fractionation schemes.
        Cancer. 1985; 55: 2086-2095
        • Jobsen J.J.
        • van der Palen J.
        • Ong F.
        • et al.
        Timing of radiotherapy and survival benefit in breast cancer.
        Breast Cancer Res Treat. 2006; 99: 289-294
        • Mackillop W.J.
        • Bates J.H.
        • O'Sullivan B.
        • et al.
        The effect of delay in treatment on local control by radiotherapy.
        Int J Radiat Oncol Biol Phys. 1996; 34: 243-250
        • Vinh-Hung V.
        • Verschraegen C.
        Breast-conserving surgery with or without radiotherapy: Pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality.
        J Natl Cancer Inst. 2004; 96: 115-121
        • Forrest A.P.
        • Steward H.J.
        • Everington D.
        • et al.
        Randomised controlled trial of conservation therapy for breast cancer: 6-Year analysis of the Scottish trial.
        Lancet. 1996; 348: 708-713
        • Livi L.
        • Paiar F.
        • Saieva C.
        • et al.
        Survival and breast relapse in 3834 patients with T1-T2 breast cancer after conserving surgery and adjuvant treatment.
        Radiother Oncol. 2007; 82: 287-293
        • The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer
        Breast radiotherapy after breast-conserving surgery.
        Can Med Assoc. 1998; 158: 535-542
        • Vujovic O.
        • Perera F.
        • Dar A.R.
        • et al.
        Does delay in breast irradiation following conservative breast surgery in node negative breast cancer patients have an impact on risk of recurrence?.
        Int J Radiat Oncol Biol Phys. 1998; 40: 869-874
        • Forrest A.P.
        • Stewart H.J.
        • Everington D.
        • et al.
        for the Scottish Cancer Trials Breast Group. Randomised controlled trial of conservation therapy for breast cancer: 6-Year analysis of the Scottish trial.
        Lancet. 1996; 348: 708-713
        • Veronesi U.
        • Luini A.
        • Del Vecchio M.
        • et al.
        Radiotherapy after breast-preserving surgery in women with localized cancer of the breast.
        N Engl J Med. 1993; 328: 1587-1591
        • Clarke D.H.
        • Lê M.G.
        • Sarrazin D.
        • et al.
        Analysis of the local regional relapses in patients with early breast cancers treated by excision and radiotherapy: Experience of the Institut Gustav-Roussy.
        Int J Radiat Oncol Biol Phys. 1985; 11: 137-145
        • Benchalal M.
        • Le Prisé E.
        • de Lafontan B.
        • et al.
        Influence of the time between surgery and radiotherapy on local recurrence in patients with lymph node-positive, early-stage, invasive breast carcinoma undergoing breast-conserving surgery: Results of the French Adjuvant Study Group.
        Cancer. 2005; 104: 240-250
        • Cèfaro G.A.
        • Genovesi D.
        • Marchese R.
        • et al.
        The effect of delaying adjuvant radiation treatment after conservative surgery for early breast cancer.
        Breast J. 2007; 13: 575-580
        • Whelan T.J.
        • Clark R.M.
        • Levine M.N.
        • et al.
        The effect of delay in initiating radiotherapy postlumpectomy on local breast recurrence.
        Int J Radiat Oncol Biol Phys. 1996; 36: 280-284
        • Nixon A.J.
        • Recht A.
        • Neuberg D.
        • et al.
        The relation between the surgery–radiotherapy interval and treatment outcome in patients treated with breast-conserving surgery and radiation therapy without systemic therapy.
        Int J Radiat Oncol Biol Phys. 1994; 30: 17-21
        • Vujovic O.
        • Cherian A.
        • Yu E.
        • et al.
        The effect of timing of radiotherapy after breast-conserving surgery in patients with positive or close resection margins, young age, and node-negative disease, with long term follow-up.
        Int J Radiat Oncol Biol Phys. 2006; 66: 687-690
        • Froud P.J.
        • Mates D.
        • Jackson J.S.
        • et al.
        Effect of time interval between breast-conserving surgery and radiation therapy on ipsilateral breast recurrence.
        Int J Radiat Oncol Biol Phys. 2000; 46: 363-372
        • Bartelink H.
        • Horiot J.C.
        • Poortmans P.M.
        • et al.
        Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-Year results of the randomized boost versus no boost EORTC 22881-10882 trial.
        J Clin Oncol. 2007; 25: 3259-3265
      1. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: An overview of the randomised trials.
        Lancet. 1998; 351: 1451-1467
        • Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
        Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials.
        Lancet. 2005; 365: 1687-1717
        • Toledano A.
        • Azria D.
        • Garaud P.
        • et al.
        Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early-stage breast cancer: Final results of the ARCOSEIN trial.
        J Clin Oncol. 2007; 25: 2334-2339
      2. Lara-Jimenez P, Garcia PJ, Pedraza V. Adjuvant combined modality treatment in high risk breast cancer patients: Ten-year results. Proceedings of the Fifth EORTC Breast Cancer Working Conference, Leuven, Belgium, September 3–6,1991.

        • Wallgren A.
        • Bernier J.
        • Gelber R.D.
        • et al.
        for the International Breast Cancer Study Group. Timing of radiotherapy and chemotherapy following breast-conserving surgery for patients with node-positive breast cancer.
        Int J Radiat Oncol Biol Phys. 1996; 35: 649-659
        • Recht A.
        • Harris J.R.
        • Come S.E.
        Sequencing of irradiation and chemotherapy for early-stage breast cancer.
        Oncology. 1994; 8: 19-28
        • Sartor C.I.
        • Peterson B.L.
        • Woolf S.
        • et al.
        Effect of addition of adjuvant paclitaxel on radiotherapy delivery and locoregional control of node-positive breast cancer: Cancer and Leukemia Group B 9344.
        J Clin Oncol. 2005; 23 (Epub 2004 Nov 15): 30-40
        • Bellon J.R.
        • Harris J.R.
        Chemotherapy and radiation therapy for breast cancer: What is the optimal sequence?.
        J Clin Oncol. 2005; 23: 5-7


      Commenting Guidelines

      To submit a comment for a journal article, please use the space above and note the following:

      • We will review submitted comments as soon as possible, striving for within two business days.
      • This forum is intended for constructive dialogue. Comments that are commercial or promotional in nature, pertain to specific medical cases, are not relevant to the article for which they have been submitted, or are otherwise inappropriate will not be posted.
      • We require that commenters identify themselves with names and affiliations.
      • Comments must be in compliance with our Terms & Conditions.
      • Comments are not peer-reviewed.